SlideShare ist ein Scribd-Unternehmen logo
1 von 35
Downloaden Sie, um offline zu lesen
1© 2015 McGee Pharma International
Data Governance Planning
October 2017
2© 2015 McGee Pharma International
|We are passionate about putting safe and
effective products in the hands of patients.
We are an award winning pharmaceutical consultancy that
combines industry leading quality and technical insight with robust
product development and commercialisation expertise.
This enables you to maximise innovation and product quality by
implementing smarter, practical solutions that allow you to focus on
what matters – ensuring your patients receive safe and effective
treatment.
3© 2015 McGee Pharma International
your partner in compliance
McGee Pharma International
Our in-house team is supported by a global network of over
90 Consultants, including a number of former EU and US
FDA Regulatory Inspectors.
Founded in 2004 by Ann McGee, a former EU Regulatory Inspector with
the HPRA, McGee Pharma International’s in-house team comprises 10
personnel in Quality / Technical, Project Management and Project Support.
4© 2015 McGee Pharma International
your partner in compliance
What we do
MPI’s services cover all product types
across the entire product lifecycle
• Large and small molecules/biotech and non-biotech
• Steriles and non-steriles
• Active Pharmaceutical Ingredients (API)
• All dosage forms
• Medical device and device combinations
• Traditional Herbal Medicines
• Cosmetics
5© 2015 McGee Pharma International
your partner in compliance
MPI’s lifecycle services
6© 2015 McGee Pharma International
your partner in compliance
Agenda
Overview of Data Integrity
Assurance of Data
Data Governance
The Data Governance Plan
Questions
7© 2015 McGee Pharma International
Overview of Data Integrity
8© 2015 McGee Pharma International
your partner in compliance
Data
A –
attributable to the
person generating
the data
L –
legible and
permanent
C –
contemporaneous
O –
original record
(or ‘true copy’)
A –
accurate
Information derived or obtained from raw data (e.g. a
reported analytical result).
Data can be ‘electronic’ or ‘paper based’
or ‘Hybrid’
However all data must be:
Source: MHRA GMP Data Integrity Definitions and Guidance for Industry
March 2015
9© 2015 McGee Pharma International
your partner in compliance
Data Integrity
Data Integrity is the extent
to which all data are
complete, consistent and
accurate throughout the
data lifecycle.
Data integrity arrangements
must ensure that the
accuracy, completeness,
content and meaning of
data is retained throughout
the data lifecycle.
Source: MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015
Patient
Safety
Product
Quality
10© 2015 McGee Pharma International
Assurance of Data Integrity
11© 2015 McGee Pharma International
your partner in compliance
How do we assure data integrity?
• Application of good documentation practices when
using paper based, electronic or hybrid – the same
rules apply……..
4.8 Records should be made or completed at
the time each action is taken and in such a way
that all significant activities concerning the
manufacture of medicinal products are traceable.
4.7 Handwritten
entries should
be made in a
clear, legible,
indelible way.
4.9 Any alteration made to the entry on a
document should be signed and dated; the
alteration should permit the reading of the
original information. Where appropriate, the
reason for the alteration should be recorded.
12© 2015 McGee Pharma International
your partner in compliance
How do we assure data integrity?
Data
creation
Data
processing
Data
review
Data
reporting
Data
retention
Use and understanding data life cycle management
Retrieval
(legibility)
13© 2015 McGee Pharma International
your partner in compliance
How do we assure data integrity?
Control of
external
environmental
factors
requires
consideration
of:
• Increasingly complex
supply chains
• Outsourcing of GxP
operations
• Economic stressors
• Technological
advances –
increased use of
electronic systems
External environmental factors
14© 2015 McGee Pharma International
your partner in compliance
How do we assure data integrity?
Control of
internal
environmental
factors
required
consideration
of:
• Quality Management
Systems
• Adequate
understanding and
control of
computerised
systems and paper
based recording
system
• Senior stakeholder
sponsorship of data
integrity assurance
activities
Internal environmental factors
15© 2015 McGee Pharma International
Data Governance
16© 2015 McGee Pharma International
your partner in compliance
Data Governance
The sum total of arrangements
to ensure that data, irrespective of
the format in which it is generated,
is recorded, processed, retained
and used to ensure a complete,
consistent and accurate record
throughout the data lifecycle
Data governance should address
data ownership throughout the
lifecycle, and consider the
design, operation and
monitoring of processes /
systems in order to comply with
the principles of data integrity
including control over intentional
and unintentional changes to
information.
Source: MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015
17© 2015 McGee Pharma International
your partner in compliance
Data Governance
The data governance system should be integral to the PQS
The effort and resource assigned should be commensurate with the
risk to product quality
• Should be balanced with other QA resource demands
The expectation is not to implement a forensic approach to data
checking on a routine basis, but to design and operate a system
which provides an acceptable state of control based risk
At its best, data governance identifies risk – both business and
compliance risk – by increasing oversight
Note: Data is not homogeneous; therefore, neither is risk
this should be considered when assigning resource
18© 2015 McGee Pharma International
your partner in compliance
Why Enterprises Struggle With Data
Governance
In the financial service industry, where data integrity
has been a concern for many years, it has been
reported in 2008 less than 10 percent of organizations
will succeed at their first attempts at data
governance.
This has been attributed to:
• Cultural barriers
• Lack of senior-level sponsorship
This statistic may prove very informative for our
industry as we embark on addressing data integrity
assurance within our organisations!!
19© 2015 McGee Pharma International
your partner in compliance
Data Governance – Application
The core of data governance
is creating a framework to
ensure that data generated is:
• Recorded
• Processed
• Retained
• Used
To ensure data, throughout the
data lifecycle, is:
• complete
• consistent
• accurate
20© 2015 McGee Pharma International
your partner in compliance
Food for thought
Manufacturers and analytical
laboratories should be aware that
reverting from automated /
computerised to manual / paper-
based systems will not in itself
remove the need for data integrity
controls.
This may also constitute a failure to
comply with Article 23 of Directive
2001/83/EC, which requires an
authorisation holder to take account
of scientific and technical progress
and enable the medicinal product to
be manufactured and checked by
means of generally accepted
scientific methods.
Source: MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015
21© 2015 McGee Pharma International
The Data Governance Plan
22© 2015 McGee Pharma International
your partner in compliance
Elements to be considered
Relevant policies,
standards
Staff training -
general & role
specific e.g. audit
team
Consideration should
be given to the
organisational controls
(e.g. procedures)
Technical controls
(e.g. computer
system access)
Effort and resource
applied should be
commensurate with
criticality in terms of
impact to product quality
attributes
An overarching data governance system, should include :
23© 2015 McGee Pharma International
your partner in compliance
Practical Elements to be considered
Systems should
be designed in a
way that
encourages
compliance e.g. :
• Access to clocks for recording timed events
• Accessibility of batch records at locations where
activities take place so that ad hoc data recording
and later transcription to official records is not
necessary
• Control over blank paper templates for data
recording
• User access rights which prevent (or audit trail)
data amendments
• Automated data capture or printers attached to
equipment such as balances
• Proximity of printers to relevant activities
• Access to sampling points (e.g. for water systems)
• Access to raw data for staff performing data
checking activities.
24© 2015 McGee Pharma International
your partner in compliance
Data Governance Plan
• The Governance Plan should consider the following
two elements:
o Prevention – better than cure!!!
o Detection – safe guarding the data!!!
Prevention1
• QMS modernisation
• CSV
• Data review policy
• Standards
• Vendors (metrics/controls)
• QTAs and templates
Detection1
• Auditing
• Identifying risk factors
• Data review process
• Whistleblower
1Not exhaustive lists
25© 2015 McGee Pharma International
your partner in compliance
Data Integrity Governance Plan
• Require a phased approach to role out –
o Consider a PDCA model
26© 2015 McGee Pharma International
your partner in compliance
Data Integrity Governance Plan- Phase 1
o Define a governance structure
 Governance at ‘senior level’, roll out a ‘grass roots’
 Appoint a Data Integrity Compliance Officer – not owner!!!
o Gain buy in from SLT & senior stakeholders
o Communications plan
o Education up and down the organisation
o Market the project to instil the appropriate culture and bring awareness
o Develop Metrics for tracking (project and DI)
o Develop a ‘Tool Kit’
 Glossary and definitions (common language)
 Policies
 Standards
 Procedures
 Whistle blowers charter and structures
 Templates – Gap Assessments, URS, SLAs, Validation, QTA, Audit etc.
27© 2015 McGee Pharma International
your partner in compliance
PQS – updates to support Data
Integrity governanceData
integrity
statement
Quality Manual
update
Development and
amendment of standards
Development and amendment of
policies
Development and amendment of
procedures
Development and amendment of templates and
forms
Cultural and
behavioural –
owned by all
championed by
quality
Training
Metrics –
expecting the
‘Bow Wave’.
Driving the
right
behaviours
28© 2015 McGee Pharma International
your partner in compliance
Data Integrity and the QRM process
Site Risk Register
SME
Close
Gaps and
identify
residual
risks
SME
Close
Gaps and
identify
residual
risks
SME
Close
Gaps and
identify
residual
risks
SME
Close
Gaps and
identify
residual
risks
SME
Close
Gaps and
identify
residual
risks
SME
Close
Gaps and
identify
residual
risks
SME
Close
Gaps and
identify
residual
risks
Data Integrity
Risk Register
& Control Strategy
Site Control Strategy
Key Gaps Key Gaps Key Gaps Key Gaps Key Gaps Key Gaps Key Gaps
Gap Assessments Required – effort commensurate with risk
Data Integrity Governance
Senior Management
Quality
Data Integrity
Compliance Office
29© 2015 McGee Pharma International
your partner in compliance
Data Integrity Governance Plan- Phase 2
o Roll out the plan
 ‘line in the sand’
o Mandated to each of the functional groups
 SMEs for actioning the activities
o Complete a Gap Assessment of current state against the ideal
 Horizontal Cut
 Qualitative assessment
 Identify low, medium and high risk areas
 ‘Deep Dive’ for the Medium, and High Risk areas –
commensurate with risk in the form of formal risk assessment
 Data lifecycle and business processing mapping
30© 2015 McGee Pharma International
your partner in compliance
Data Integrity Governance Plan- Phase 2
Identification of risks for tracking –
role up residual risk into quality risk
register for organisation
Risk
Assessment
Deviations
CAPA
SOP
Detailed data
lifecycle and
business
processing
mapping
Identify
High
Medium
Low risk
Identify
controls
commensurate
with risk
31© 2015 McGee Pharma International
your partner in compliance
Data Integrity Governance Plan- Phase 3 & 4
• Check – Phase 3
o Governance team provide tracking and oversight during ‘do’
phase – tracking against project roll out
o Important to understand that in the initial phase metrics may
appear to look worse as issues are detected through the gap
assessment and QRM activities
 Communication of this potential ‘Bow Wave’ effect is important
o Quick wins actions
o Long term actions
• Act – Phase 4 – Sustain
o Incorporate DI metrics into the Quality Management Review
process and track
o Incorporate DI into the self inspection & vendor qualification
and oversight programs
32© 2015 McGee Pharma International
Summary
33© 2015 McGee Pharma International
your partner in compliance
Summary
Overview of Data Integrity
•Applies to all data sources
•Patient Safety and Product Quality
Assurance of Data
•Paper based, electronic or hybrid – the same rules apply (ALCOA)
•Assuring appropriate data life cycle management
•Identifying and controlling internal and external factors
Data Governance
•The core of data governance is creating a framework to ensure that data generated is recorded, processed, retained &
used to ensure complete, consistent & accurate throughout the life cycle
•Cultural barriers and lack of senior-level sponsorship may be potential obstacles
•Reverting from automated / computerised to manual / paper-based systems will not in itself remove the need for data
integrity controls
The Data Governance Plan
•Should consider prevention and detection
•Relevant policies, standards, staff training, consideration should be given to the organisational controls , technical
controls
•Effort and resource applied should be commensurate with criticality in terms of impact to product quality attributes
• Governance at a Management Level and roll out at a grass roots
•Things may appear worse before they get better – metrics
•PQS, QRM and QMR
34© 2015 McGee Pharma International
your partner in compliance
Questions?
35© 2015 McGee Pharma International
Contact
A | Suite 2, Stafford House, Strand Road, Portmarnock, Co. Dublin, Ireland
P | +353 (0)1 846 47 42 E | info@mcgeepharma.com
F | +353 (0)1 846 4898 W| www.mcgeepharma.com

Weitere ähnliche Inhalte

Was ist angesagt?

How to Review, Cleanse, and Transform Clinical Data in Oracle InForm
How to Review, Cleanse, and Transform Clinical Data in Oracle InFormHow to Review, Cleanse, and Transform Clinical Data in Oracle InForm
How to Review, Cleanse, and Transform Clinical Data in Oracle InFormPerficient, Inc.
 
Managing an end to end Pharmacovigilance system from affiliates to regulatory...
Managing an end to end Pharmacovigilance system from affiliates to regulatory...Managing an end to end Pharmacovigilance system from affiliates to regulatory...
Managing an end to end Pharmacovigilance system from affiliates to regulatory...MyMeds&Me
 
Mr. Brian Sterling - Traceability: How to Leverage the Lessons from Others
Mr. Brian Sterling - Traceability: How to Leverage the Lessons from OthersMr. Brian Sterling - Traceability: How to Leverage the Lessons from Others
Mr. Brian Sterling - Traceability: How to Leverage the Lessons from OthersJohn Blue
 
Leveraging Oracle IDMP Enterprise Foundation Suite for Regulatory Compliance
Leveraging Oracle IDMP Enterprise Foundation Suite for Regulatory ComplianceLeveraging Oracle IDMP Enterprise Foundation Suite for Regulatory Compliance
Leveraging Oracle IDMP Enterprise Foundation Suite for Regulatory CompliancePerficient, Inc.
 
47609097 meditech-surgical
47609097 meditech-surgical47609097 meditech-surgical
47609097 meditech-surgicalyatokst
 
Driving risk management through intelligent intake technology
Driving risk management through intelligent intake technologyDriving risk management through intelligent intake technology
Driving risk management through intelligent intake technologyMyMeds&Me
 
The Value of an Engaged Workforce for the Food Industry
The Value of an Engaged Workforce for the Food IndustryThe Value of an Engaged Workforce for the Food Industry
The Value of an Engaged Workforce for the Food IndustryAlchemy Systems
 
Anaphalaxis campaign presentation sw
Anaphalaxis campaign presentation swAnaphalaxis campaign presentation sw
Anaphalaxis campaign presentation swanaphylaxiscampaign
 
Case Study Scm
Case Study ScmCase Study Scm
Case Study ScmDeben Rock
 
Plan for Success Strategies to Align Reimbursement and Commercialization - OM...
Plan for Success Strategies to Align Reimbursement and Commercialization - OM...Plan for Success Strategies to Align Reimbursement and Commercialization - OM...
Plan for Success Strategies to Align Reimbursement and Commercialization - OM...April Bright
 

Was ist angesagt? (20)

Llc good soft
Llc  good softLlc  good soft
Llc good soft
 
How to Review, Cleanse, and Transform Clinical Data in Oracle InForm
How to Review, Cleanse, and Transform Clinical Data in Oracle InFormHow to Review, Cleanse, and Transform Clinical Data in Oracle InForm
How to Review, Cleanse, and Transform Clinical Data in Oracle InForm
 
RIM & IDMP Synergies
RIM & IDMP SynergiesRIM & IDMP Synergies
RIM & IDMP Synergies
 
Managing an end to end Pharmacovigilance system from affiliates to regulatory...
Managing an end to end Pharmacovigilance system from affiliates to regulatory...Managing an end to end Pharmacovigilance system from affiliates to regulatory...
Managing an end to end Pharmacovigilance system from affiliates to regulatory...
 
MHRA Data Integrity Requirements
MHRA Data Integrity RequirementsMHRA Data Integrity Requirements
MHRA Data Integrity Requirements
 
Mr. Brian Sterling - Traceability: How to Leverage the Lessons from Others
Mr. Brian Sterling - Traceability: How to Leverage the Lessons from OthersMr. Brian Sterling - Traceability: How to Leverage the Lessons from Others
Mr. Brian Sterling - Traceability: How to Leverage the Lessons from Others
 
GoodSoft
GoodSoft GoodSoft
GoodSoft
 
GoodSoft
GoodSoft GoodSoft
GoodSoft
 
Leveraging Oracle IDMP Enterprise Foundation Suite for Regulatory Compliance
Leveraging Oracle IDMP Enterprise Foundation Suite for Regulatory ComplianceLeveraging Oracle IDMP Enterprise Foundation Suite for Regulatory Compliance
Leveraging Oracle IDMP Enterprise Foundation Suite for Regulatory Compliance
 
47609097 meditech-surgical
47609097 meditech-surgical47609097 meditech-surgical
47609097 meditech-surgical
 
Driving risk management through intelligent intake technology
Driving risk management through intelligent intake technologyDriving risk management through intelligent intake technology
Driving risk management through intelligent intake technology
 
Calculation of Risk Priority Numbar
Calculation of  Risk Priority NumbarCalculation of  Risk Priority Numbar
Calculation of Risk Priority Numbar
 
New gdp's for medicinal products
New gdp's for medicinal productsNew gdp's for medicinal products
New gdp's for medicinal products
 
The Value of an Engaged Workforce for the Food Industry
The Value of an Engaged Workforce for the Food IndustryThe Value of an Engaged Workforce for the Food Industry
The Value of an Engaged Workforce for the Food Industry
 
Healthcare logistics for service improvement
Healthcare logistics for service improvementHealthcare logistics for service improvement
Healthcare logistics for service improvement
 
Anaphalaxis campaign presentation sw
Anaphalaxis campaign presentation swAnaphalaxis campaign presentation sw
Anaphalaxis campaign presentation sw
 
Case Study Scm
Case Study ScmCase Study Scm
Case Study Scm
 
Plan for Success Strategies to Align Reimbursement and Commercialization - OM...
Plan for Success Strategies to Align Reimbursement and Commercialization - OM...Plan for Success Strategies to Align Reimbursement and Commercialization - OM...
Plan for Success Strategies to Align Reimbursement and Commercialization - OM...
 
Meditech surgical
Meditech surgicalMeditech surgical
Meditech surgical
 
john daniels
john danielsjohn daniels
john daniels
 

Ähnlich wie Data Goverance Planning

Quick Overview: Pharmaceutical Data Integrity
Quick Overview: Pharmaceutical Data IntegrityQuick Overview: Pharmaceutical Data Integrity
Quick Overview: Pharmaceutical Data IntegrityPeter Dellva
 
Data Integrity webinar - Essentials & Solutions
Data Integrity webinar - Essentials & SolutionsData Integrity webinar - Essentials & Solutions
Data Integrity webinar - Essentials & Solutionspi
 
Responsibly Managing Supply Chain Chemical Compliance in the Decade of Regula...
Responsibly Managing Supply Chain Chemical Compliance in the Decade of Regula...Responsibly Managing Supply Chain Chemical Compliance in the Decade of Regula...
Responsibly Managing Supply Chain Chemical Compliance in the Decade of Regula...Baytouch Solutions
 
TransCelerate Overview - Quality Management System Initiave
TransCelerate Overview - Quality Management System Initiave TransCelerate Overview - Quality Management System Initiave
TransCelerate Overview - Quality Management System Initiave TransCelerate
 
FDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection IntelligenceFDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection IntelligenceArmin Torres
 
FDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection IntelligenceFDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection IntelligenceArmin Torres
 
Pharmacovigilance Auditing: Ensuring Data Integrity and Compliance
Pharmacovigilance Auditing: Ensuring Data Integrity and CompliancePharmacovigilance Auditing: Ensuring Data Integrity and Compliance
Pharmacovigilance Auditing: Ensuring Data Integrity and ComplianceClinosolIndia
 
2016-06-08 FDA Inspection Readiness - Mikael Yde
2016-06-08 FDA Inspection Readiness - Mikael Yde2016-06-08 FDA Inspection Readiness - Mikael Yde
2016-06-08 FDA Inspection Readiness - Mikael Ydemikaelyde
 
Presentation: An Update on post-market regulatory requirements
Presentation: An Update on post-market regulatory requirementsPresentation: An Update on post-market regulatory requirements
Presentation: An Update on post-market regulatory requirementsTGA Australia
 
What is New in Track and Trace Technology?
What is New in Track and Trace Technology?What is New in Track and Trace Technology?
What is New in Track and Trace Technology?Angela Carver
 
Financial Services - New Approach to Data Management in the Digital Era
Financial Services - New Approach to Data Management in the Digital EraFinancial Services - New Approach to Data Management in the Digital Era
Financial Services - New Approach to Data Management in the Digital Eraaccenture
 
Enterprise policy-management
Enterprise policy-managementEnterprise policy-management
Enterprise policy-managementAmit Bhargava
 
Presentation: Data Integrity – an international regulatory perspective
Presentation: Data Integrity – an international regulatory perspectivePresentation: Data Integrity – an international regulatory perspective
Presentation: Data Integrity – an international regulatory perspectiveTGA Australia
 
Dr. Dan Mingle's Overview of the 2015 Medicare Final Rule
Dr. Dan Mingle's Overview of the 2015 Medicare Final RuleDr. Dan Mingle's Overview of the 2015 Medicare Final Rule
Dr. Dan Mingle's Overview of the 2015 Medicare Final RuleMingle Analytics
 
Tackling the Challanges of Pharma Manufacturing
Tackling the Challanges of Pharma ManufacturingTackling the Challanges of Pharma Manufacturing
Tackling the Challanges of Pharma ManufacturingJason Corder
 
Data integrity: TGA expectations
Data integrity: TGA expectationsData integrity: TGA expectations
Data integrity: TGA expectationsTGA Australia
 
Clinical Data Management importance in Clinical Trials
Clinical Data Management importance in Clinical TrialsClinical Data Management importance in Clinical Trials
Clinical Data Management importance in Clinical TrialsClinosolIndia
 

Ähnlich wie Data Goverance Planning (20)

Quick Overview: Pharmaceutical Data Integrity
Quick Overview: Pharmaceutical Data IntegrityQuick Overview: Pharmaceutical Data Integrity
Quick Overview: Pharmaceutical Data Integrity
 
Data Integrity
Data IntegrityData Integrity
Data Integrity
 
Data Integrity webinar - Essentials & Solutions
Data Integrity webinar - Essentials & SolutionsData Integrity webinar - Essentials & Solutions
Data Integrity webinar - Essentials & Solutions
 
Responsibly Managing Supply Chain Chemical Compliance in the Decade of Regula...
Responsibly Managing Supply Chain Chemical Compliance in the Decade of Regula...Responsibly Managing Supply Chain Chemical Compliance in the Decade of Regula...
Responsibly Managing Supply Chain Chemical Compliance in the Decade of Regula...
 
TransCelerate Overview - Quality Management System Initiave
TransCelerate Overview - Quality Management System Initiave TransCelerate Overview - Quality Management System Initiave
TransCelerate Overview - Quality Management System Initiave
 
FDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection IntelligenceFDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection Intelligence
 
FDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection IntelligenceFDA News Webinar - Inspection Intelligence
FDA News Webinar - Inspection Intelligence
 
Pharmacovigilance Auditing: Ensuring Data Integrity and Compliance
Pharmacovigilance Auditing: Ensuring Data Integrity and CompliancePharmacovigilance Auditing: Ensuring Data Integrity and Compliance
Pharmacovigilance Auditing: Ensuring Data Integrity and Compliance
 
2016-06-08 FDA Inspection Readiness - Mikael Yde
2016-06-08 FDA Inspection Readiness - Mikael Yde2016-06-08 FDA Inspection Readiness - Mikael Yde
2016-06-08 FDA Inspection Readiness - Mikael Yde
 
Presentation: An Update on post-market regulatory requirements
Presentation: An Update on post-market regulatory requirementsPresentation: An Update on post-market regulatory requirements
Presentation: An Update on post-market regulatory requirements
 
Unlocking the power of digital healthcare
Unlocking the power of digital healthcareUnlocking the power of digital healthcare
Unlocking the power of digital healthcare
 
What is New in Track and Trace Technology?
What is New in Track and Trace Technology?What is New in Track and Trace Technology?
What is New in Track and Trace Technology?
 
Phụ lục 5 GMP WHO - Nguyên tắc lưu trữ tài liệu, hồ sơ
Phụ lục 5 GMP WHO - Nguyên tắc lưu trữ tài liệu, hồ sơPhụ lục 5 GMP WHO - Nguyên tắc lưu trữ tài liệu, hồ sơ
Phụ lục 5 GMP WHO - Nguyên tắc lưu trữ tài liệu, hồ sơ
 
Financial Services - New Approach to Data Management in the Digital Era
Financial Services - New Approach to Data Management in the Digital EraFinancial Services - New Approach to Data Management in the Digital Era
Financial Services - New Approach to Data Management in the Digital Era
 
Enterprise policy-management
Enterprise policy-managementEnterprise policy-management
Enterprise policy-management
 
Presentation: Data Integrity – an international regulatory perspective
Presentation: Data Integrity – an international regulatory perspectivePresentation: Data Integrity – an international regulatory perspective
Presentation: Data Integrity – an international regulatory perspective
 
Dr. Dan Mingle's Overview of the 2015 Medicare Final Rule
Dr. Dan Mingle's Overview of the 2015 Medicare Final RuleDr. Dan Mingle's Overview of the 2015 Medicare Final Rule
Dr. Dan Mingle's Overview of the 2015 Medicare Final Rule
 
Tackling the Challanges of Pharma Manufacturing
Tackling the Challanges of Pharma ManufacturingTackling the Challanges of Pharma Manufacturing
Tackling the Challanges of Pharma Manufacturing
 
Data integrity: TGA expectations
Data integrity: TGA expectationsData integrity: TGA expectations
Data integrity: TGA expectations
 
Clinical Data Management importance in Clinical Trials
Clinical Data Management importance in Clinical TrialsClinical Data Management importance in Clinical Trials
Clinical Data Management importance in Clinical Trials
 

Kürzlich hochgeladen

Call Girls in Sarai Kale Khan Delhi 💯 Call Us 🔝9205541914 🔝( Delhi) Escorts S...
Call Girls in Sarai Kale Khan Delhi 💯 Call Us 🔝9205541914 🔝( Delhi) Escorts S...Call Girls in Sarai Kale Khan Delhi 💯 Call Us 🔝9205541914 🔝( Delhi) Escorts S...
Call Girls in Sarai Kale Khan Delhi 💯 Call Us 🔝9205541914 🔝( Delhi) Escorts S...Delhi Call girls
 
Accredited-Transport-Cooperatives-Jan-2021-Web.pdf
Accredited-Transport-Cooperatives-Jan-2021-Web.pdfAccredited-Transport-Cooperatives-Jan-2021-Web.pdf
Accredited-Transport-Cooperatives-Jan-2021-Web.pdfadriantubila
 
FESE Capital Markets Fact Sheet 2024 Q1.pdf
FESE Capital Markets Fact Sheet 2024 Q1.pdfFESE Capital Markets Fact Sheet 2024 Q1.pdf
FESE Capital Markets Fact Sheet 2024 Q1.pdfMarinCaroMartnezBerg
 
{Pooja: 9892124323 } Call Girl in Mumbai | Jas Kaur Rate 4500 Free Hotel Del...
{Pooja:  9892124323 } Call Girl in Mumbai | Jas Kaur Rate 4500 Free Hotel Del...{Pooja:  9892124323 } Call Girl in Mumbai | Jas Kaur Rate 4500 Free Hotel Del...
{Pooja: 9892124323 } Call Girl in Mumbai | Jas Kaur Rate 4500 Free Hotel Del...Pooja Nehwal
 
VIP Call Girls Service Miyapur Hyderabad Call +91-8250192130
VIP Call Girls Service Miyapur Hyderabad Call +91-8250192130VIP Call Girls Service Miyapur Hyderabad Call +91-8250192130
VIP Call Girls Service Miyapur Hyderabad Call +91-8250192130Suhani Kapoor
 
BPAC WITH UFSBI GENERAL PRESENTATION 18_05_2017-1.pptx
BPAC WITH UFSBI GENERAL PRESENTATION 18_05_2017-1.pptxBPAC WITH UFSBI GENERAL PRESENTATION 18_05_2017-1.pptx
BPAC WITH UFSBI GENERAL PRESENTATION 18_05_2017-1.pptxMohammedJunaid861692
 
Best VIP Call Girls Noida Sector 39 Call Me: 8448380779
Best VIP Call Girls Noida Sector 39 Call Me: 8448380779Best VIP Call Girls Noida Sector 39 Call Me: 8448380779
Best VIP Call Girls Noida Sector 39 Call Me: 8448380779Delhi Call girls
 
Capstone Project on IBM Data Analytics Program
Capstone Project on IBM Data Analytics ProgramCapstone Project on IBM Data Analytics Program
Capstone Project on IBM Data Analytics ProgramMoniSankarHazra
 
Ravak dropshipping via API with DroFx.pptx
Ravak dropshipping via API with DroFx.pptxRavak dropshipping via API with DroFx.pptx
Ravak dropshipping via API with DroFx.pptxolyaivanovalion
 
Carero dropshipping via API with DroFx.pptx
Carero dropshipping via API with DroFx.pptxCarero dropshipping via API with DroFx.pptx
Carero dropshipping via API with DroFx.pptxolyaivanovalion
 
Cheap Rate Call girls Sarita Vihar Delhi 9205541914 shot 1500 night
Cheap Rate Call girls Sarita Vihar Delhi 9205541914 shot 1500 nightCheap Rate Call girls Sarita Vihar Delhi 9205541914 shot 1500 night
Cheap Rate Call girls Sarita Vihar Delhi 9205541914 shot 1500 nightDelhi Call girls
 
Invezz.com - Grow your wealth with trading signals
Invezz.com - Grow your wealth with trading signalsInvezz.com - Grow your wealth with trading signals
Invezz.com - Grow your wealth with trading signalsInvezz1
 
Mature dropshipping via API with DroFx.pptx
Mature dropshipping via API with DroFx.pptxMature dropshipping via API with DroFx.pptx
Mature dropshipping via API with DroFx.pptxolyaivanovalion
 
꧁❤ Greater Noida Call Girls Delhi ❤꧂ 9711199171 ☎️ Hard And Sexy Vip Call
꧁❤ Greater Noida Call Girls Delhi ❤꧂ 9711199171 ☎️ Hard And Sexy Vip Call꧁❤ Greater Noida Call Girls Delhi ❤꧂ 9711199171 ☎️ Hard And Sexy Vip Call
꧁❤ Greater Noida Call Girls Delhi ❤꧂ 9711199171 ☎️ Hard And Sexy Vip Callshivangimorya083
 
Data-Analysis for Chicago Crime Data 2023
Data-Analysis for Chicago Crime Data  2023Data-Analysis for Chicago Crime Data  2023
Data-Analysis for Chicago Crime Data 2023ymrp368
 
(PARI) Call Girls Wanowrie ( 7001035870 ) HI-Fi Pune Escorts Service
(PARI) Call Girls Wanowrie ( 7001035870 ) HI-Fi Pune Escorts Service(PARI) Call Girls Wanowrie ( 7001035870 ) HI-Fi Pune Escorts Service
(PARI) Call Girls Wanowrie ( 7001035870 ) HI-Fi Pune Escorts Serviceranjana rawat
 
Delhi Call Girls CP 9711199171 ☎✔👌✔ Whatsapp Hard And Sexy Vip Call
Delhi Call Girls CP 9711199171 ☎✔👌✔ Whatsapp Hard And Sexy Vip CallDelhi Call Girls CP 9711199171 ☎✔👌✔ Whatsapp Hard And Sexy Vip Call
Delhi Call Girls CP 9711199171 ☎✔👌✔ Whatsapp Hard And Sexy Vip Callshivangimorya083
 

Kürzlich hochgeladen (20)

CHEAP Call Girls in Saket (-DELHI )🔝 9953056974🔝(=)/CALL GIRLS SERVICE
CHEAP Call Girls in Saket (-DELHI )🔝 9953056974🔝(=)/CALL GIRLS SERVICECHEAP Call Girls in Saket (-DELHI )🔝 9953056974🔝(=)/CALL GIRLS SERVICE
CHEAP Call Girls in Saket (-DELHI )🔝 9953056974🔝(=)/CALL GIRLS SERVICE
 
Call Girls in Sarai Kale Khan Delhi 💯 Call Us 🔝9205541914 🔝( Delhi) Escorts S...
Call Girls in Sarai Kale Khan Delhi 💯 Call Us 🔝9205541914 🔝( Delhi) Escorts S...Call Girls in Sarai Kale Khan Delhi 💯 Call Us 🔝9205541914 🔝( Delhi) Escorts S...
Call Girls in Sarai Kale Khan Delhi 💯 Call Us 🔝9205541914 🔝( Delhi) Escorts S...
 
Accredited-Transport-Cooperatives-Jan-2021-Web.pdf
Accredited-Transport-Cooperatives-Jan-2021-Web.pdfAccredited-Transport-Cooperatives-Jan-2021-Web.pdf
Accredited-Transport-Cooperatives-Jan-2021-Web.pdf
 
FESE Capital Markets Fact Sheet 2024 Q1.pdf
FESE Capital Markets Fact Sheet 2024 Q1.pdfFESE Capital Markets Fact Sheet 2024 Q1.pdf
FESE Capital Markets Fact Sheet 2024 Q1.pdf
 
{Pooja: 9892124323 } Call Girl in Mumbai | Jas Kaur Rate 4500 Free Hotel Del...
{Pooja:  9892124323 } Call Girl in Mumbai | Jas Kaur Rate 4500 Free Hotel Del...{Pooja:  9892124323 } Call Girl in Mumbai | Jas Kaur Rate 4500 Free Hotel Del...
{Pooja: 9892124323 } Call Girl in Mumbai | Jas Kaur Rate 4500 Free Hotel Del...
 
VIP Call Girls Service Miyapur Hyderabad Call +91-8250192130
VIP Call Girls Service Miyapur Hyderabad Call +91-8250192130VIP Call Girls Service Miyapur Hyderabad Call +91-8250192130
VIP Call Girls Service Miyapur Hyderabad Call +91-8250192130
 
Delhi 99530 vip 56974 Genuine Escort Service Call Girls in Kishangarh
Delhi 99530 vip 56974 Genuine Escort Service Call Girls in  KishangarhDelhi 99530 vip 56974 Genuine Escort Service Call Girls in  Kishangarh
Delhi 99530 vip 56974 Genuine Escort Service Call Girls in Kishangarh
 
BPAC WITH UFSBI GENERAL PRESENTATION 18_05_2017-1.pptx
BPAC WITH UFSBI GENERAL PRESENTATION 18_05_2017-1.pptxBPAC WITH UFSBI GENERAL PRESENTATION 18_05_2017-1.pptx
BPAC WITH UFSBI GENERAL PRESENTATION 18_05_2017-1.pptx
 
Best VIP Call Girls Noida Sector 39 Call Me: 8448380779
Best VIP Call Girls Noida Sector 39 Call Me: 8448380779Best VIP Call Girls Noida Sector 39 Call Me: 8448380779
Best VIP Call Girls Noida Sector 39 Call Me: 8448380779
 
Capstone Project on IBM Data Analytics Program
Capstone Project on IBM Data Analytics ProgramCapstone Project on IBM Data Analytics Program
Capstone Project on IBM Data Analytics Program
 
Ravak dropshipping via API with DroFx.pptx
Ravak dropshipping via API with DroFx.pptxRavak dropshipping via API with DroFx.pptx
Ravak dropshipping via API with DroFx.pptx
 
Carero dropshipping via API with DroFx.pptx
Carero dropshipping via API with DroFx.pptxCarero dropshipping via API with DroFx.pptx
Carero dropshipping via API with DroFx.pptx
 
Cheap Rate Call girls Sarita Vihar Delhi 9205541914 shot 1500 night
Cheap Rate Call girls Sarita Vihar Delhi 9205541914 shot 1500 nightCheap Rate Call girls Sarita Vihar Delhi 9205541914 shot 1500 night
Cheap Rate Call girls Sarita Vihar Delhi 9205541914 shot 1500 night
 
Invezz.com - Grow your wealth with trading signals
Invezz.com - Grow your wealth with trading signalsInvezz.com - Grow your wealth with trading signals
Invezz.com - Grow your wealth with trading signals
 
Mature dropshipping via API with DroFx.pptx
Mature dropshipping via API with DroFx.pptxMature dropshipping via API with DroFx.pptx
Mature dropshipping via API with DroFx.pptx
 
꧁❤ Greater Noida Call Girls Delhi ❤꧂ 9711199171 ☎️ Hard And Sexy Vip Call
꧁❤ Greater Noida Call Girls Delhi ❤꧂ 9711199171 ☎️ Hard And Sexy Vip Call꧁❤ Greater Noida Call Girls Delhi ❤꧂ 9711199171 ☎️ Hard And Sexy Vip Call
꧁❤ Greater Noida Call Girls Delhi ❤꧂ 9711199171 ☎️ Hard And Sexy Vip Call
 
Data-Analysis for Chicago Crime Data 2023
Data-Analysis for Chicago Crime Data  2023Data-Analysis for Chicago Crime Data  2023
Data-Analysis for Chicago Crime Data 2023
 
Sampling (random) method and Non random.ppt
Sampling (random) method and Non random.pptSampling (random) method and Non random.ppt
Sampling (random) method and Non random.ppt
 
(PARI) Call Girls Wanowrie ( 7001035870 ) HI-Fi Pune Escorts Service
(PARI) Call Girls Wanowrie ( 7001035870 ) HI-Fi Pune Escorts Service(PARI) Call Girls Wanowrie ( 7001035870 ) HI-Fi Pune Escorts Service
(PARI) Call Girls Wanowrie ( 7001035870 ) HI-Fi Pune Escorts Service
 
Delhi Call Girls CP 9711199171 ☎✔👌✔ Whatsapp Hard And Sexy Vip Call
Delhi Call Girls CP 9711199171 ☎✔👌✔ Whatsapp Hard And Sexy Vip CallDelhi Call Girls CP 9711199171 ☎✔👌✔ Whatsapp Hard And Sexy Vip Call
Delhi Call Girls CP 9711199171 ☎✔👌✔ Whatsapp Hard And Sexy Vip Call
 

Data Goverance Planning

  • 1. 1© 2015 McGee Pharma International Data Governance Planning October 2017
  • 2. 2© 2015 McGee Pharma International |We are passionate about putting safe and effective products in the hands of patients. We are an award winning pharmaceutical consultancy that combines industry leading quality and technical insight with robust product development and commercialisation expertise. This enables you to maximise innovation and product quality by implementing smarter, practical solutions that allow you to focus on what matters – ensuring your patients receive safe and effective treatment.
  • 3. 3© 2015 McGee Pharma International your partner in compliance McGee Pharma International Our in-house team is supported by a global network of over 90 Consultants, including a number of former EU and US FDA Regulatory Inspectors. Founded in 2004 by Ann McGee, a former EU Regulatory Inspector with the HPRA, McGee Pharma International’s in-house team comprises 10 personnel in Quality / Technical, Project Management and Project Support.
  • 4. 4© 2015 McGee Pharma International your partner in compliance What we do MPI’s services cover all product types across the entire product lifecycle • Large and small molecules/biotech and non-biotech • Steriles and non-steriles • Active Pharmaceutical Ingredients (API) • All dosage forms • Medical device and device combinations • Traditional Herbal Medicines • Cosmetics
  • 5. 5© 2015 McGee Pharma International your partner in compliance MPI’s lifecycle services
  • 6. 6© 2015 McGee Pharma International your partner in compliance Agenda Overview of Data Integrity Assurance of Data Data Governance The Data Governance Plan Questions
  • 7. 7© 2015 McGee Pharma International Overview of Data Integrity
  • 8. 8© 2015 McGee Pharma International your partner in compliance Data A – attributable to the person generating the data L – legible and permanent C – contemporaneous O – original record (or ‘true copy’) A – accurate Information derived or obtained from raw data (e.g. a reported analytical result). Data can be ‘electronic’ or ‘paper based’ or ‘Hybrid’ However all data must be: Source: MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015
  • 9. 9© 2015 McGee Pharma International your partner in compliance Data Integrity Data Integrity is the extent to which all data are complete, consistent and accurate throughout the data lifecycle. Data integrity arrangements must ensure that the accuracy, completeness, content and meaning of data is retained throughout the data lifecycle. Source: MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015 Patient Safety Product Quality
  • 10. 10© 2015 McGee Pharma International Assurance of Data Integrity
  • 11. 11© 2015 McGee Pharma International your partner in compliance How do we assure data integrity? • Application of good documentation practices when using paper based, electronic or hybrid – the same rules apply…….. 4.8 Records should be made or completed at the time each action is taken and in such a way that all significant activities concerning the manufacture of medicinal products are traceable. 4.7 Handwritten entries should be made in a clear, legible, indelible way. 4.9 Any alteration made to the entry on a document should be signed and dated; the alteration should permit the reading of the original information. Where appropriate, the reason for the alteration should be recorded.
  • 12. 12© 2015 McGee Pharma International your partner in compliance How do we assure data integrity? Data creation Data processing Data review Data reporting Data retention Use and understanding data life cycle management Retrieval (legibility)
  • 13. 13© 2015 McGee Pharma International your partner in compliance How do we assure data integrity? Control of external environmental factors requires consideration of: • Increasingly complex supply chains • Outsourcing of GxP operations • Economic stressors • Technological advances – increased use of electronic systems External environmental factors
  • 14. 14© 2015 McGee Pharma International your partner in compliance How do we assure data integrity? Control of internal environmental factors required consideration of: • Quality Management Systems • Adequate understanding and control of computerised systems and paper based recording system • Senior stakeholder sponsorship of data integrity assurance activities Internal environmental factors
  • 15. 15© 2015 McGee Pharma International Data Governance
  • 16. 16© 2015 McGee Pharma International your partner in compliance Data Governance The sum total of arrangements to ensure that data, irrespective of the format in which it is generated, is recorded, processed, retained and used to ensure a complete, consistent and accurate record throughout the data lifecycle Data governance should address data ownership throughout the lifecycle, and consider the design, operation and monitoring of processes / systems in order to comply with the principles of data integrity including control over intentional and unintentional changes to information. Source: MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015
  • 17. 17© 2015 McGee Pharma International your partner in compliance Data Governance The data governance system should be integral to the PQS The effort and resource assigned should be commensurate with the risk to product quality • Should be balanced with other QA resource demands The expectation is not to implement a forensic approach to data checking on a routine basis, but to design and operate a system which provides an acceptable state of control based risk At its best, data governance identifies risk – both business and compliance risk – by increasing oversight Note: Data is not homogeneous; therefore, neither is risk this should be considered when assigning resource
  • 18. 18© 2015 McGee Pharma International your partner in compliance Why Enterprises Struggle With Data Governance In the financial service industry, where data integrity has been a concern for many years, it has been reported in 2008 less than 10 percent of organizations will succeed at their first attempts at data governance. This has been attributed to: • Cultural barriers • Lack of senior-level sponsorship This statistic may prove very informative for our industry as we embark on addressing data integrity assurance within our organisations!!
  • 19. 19© 2015 McGee Pharma International your partner in compliance Data Governance – Application The core of data governance is creating a framework to ensure that data generated is: • Recorded • Processed • Retained • Used To ensure data, throughout the data lifecycle, is: • complete • consistent • accurate
  • 20. 20© 2015 McGee Pharma International your partner in compliance Food for thought Manufacturers and analytical laboratories should be aware that reverting from automated / computerised to manual / paper- based systems will not in itself remove the need for data integrity controls. This may also constitute a failure to comply with Article 23 of Directive 2001/83/EC, which requires an authorisation holder to take account of scientific and technical progress and enable the medicinal product to be manufactured and checked by means of generally accepted scientific methods. Source: MHRA GMP Data Integrity Definitions and Guidance for Industry March 2015
  • 21. 21© 2015 McGee Pharma International The Data Governance Plan
  • 22. 22© 2015 McGee Pharma International your partner in compliance Elements to be considered Relevant policies, standards Staff training - general & role specific e.g. audit team Consideration should be given to the organisational controls (e.g. procedures) Technical controls (e.g. computer system access) Effort and resource applied should be commensurate with criticality in terms of impact to product quality attributes An overarching data governance system, should include :
  • 23. 23© 2015 McGee Pharma International your partner in compliance Practical Elements to be considered Systems should be designed in a way that encourages compliance e.g. : • Access to clocks for recording timed events • Accessibility of batch records at locations where activities take place so that ad hoc data recording and later transcription to official records is not necessary • Control over blank paper templates for data recording • User access rights which prevent (or audit trail) data amendments • Automated data capture or printers attached to equipment such as balances • Proximity of printers to relevant activities • Access to sampling points (e.g. for water systems) • Access to raw data for staff performing data checking activities.
  • 24. 24© 2015 McGee Pharma International your partner in compliance Data Governance Plan • The Governance Plan should consider the following two elements: o Prevention – better than cure!!! o Detection – safe guarding the data!!! Prevention1 • QMS modernisation • CSV • Data review policy • Standards • Vendors (metrics/controls) • QTAs and templates Detection1 • Auditing • Identifying risk factors • Data review process • Whistleblower 1Not exhaustive lists
  • 25. 25© 2015 McGee Pharma International your partner in compliance Data Integrity Governance Plan • Require a phased approach to role out – o Consider a PDCA model
  • 26. 26© 2015 McGee Pharma International your partner in compliance Data Integrity Governance Plan- Phase 1 o Define a governance structure  Governance at ‘senior level’, roll out a ‘grass roots’  Appoint a Data Integrity Compliance Officer – not owner!!! o Gain buy in from SLT & senior stakeholders o Communications plan o Education up and down the organisation o Market the project to instil the appropriate culture and bring awareness o Develop Metrics for tracking (project and DI) o Develop a ‘Tool Kit’  Glossary and definitions (common language)  Policies  Standards  Procedures  Whistle blowers charter and structures  Templates – Gap Assessments, URS, SLAs, Validation, QTA, Audit etc.
  • 27. 27© 2015 McGee Pharma International your partner in compliance PQS – updates to support Data Integrity governanceData integrity statement Quality Manual update Development and amendment of standards Development and amendment of policies Development and amendment of procedures Development and amendment of templates and forms Cultural and behavioural – owned by all championed by quality Training Metrics – expecting the ‘Bow Wave’. Driving the right behaviours
  • 28. 28© 2015 McGee Pharma International your partner in compliance Data Integrity and the QRM process Site Risk Register SME Close Gaps and identify residual risks SME Close Gaps and identify residual risks SME Close Gaps and identify residual risks SME Close Gaps and identify residual risks SME Close Gaps and identify residual risks SME Close Gaps and identify residual risks SME Close Gaps and identify residual risks Data Integrity Risk Register & Control Strategy Site Control Strategy Key Gaps Key Gaps Key Gaps Key Gaps Key Gaps Key Gaps Key Gaps Gap Assessments Required – effort commensurate with risk Data Integrity Governance Senior Management Quality Data Integrity Compliance Office
  • 29. 29© 2015 McGee Pharma International your partner in compliance Data Integrity Governance Plan- Phase 2 o Roll out the plan  ‘line in the sand’ o Mandated to each of the functional groups  SMEs for actioning the activities o Complete a Gap Assessment of current state against the ideal  Horizontal Cut  Qualitative assessment  Identify low, medium and high risk areas  ‘Deep Dive’ for the Medium, and High Risk areas – commensurate with risk in the form of formal risk assessment  Data lifecycle and business processing mapping
  • 30. 30© 2015 McGee Pharma International your partner in compliance Data Integrity Governance Plan- Phase 2 Identification of risks for tracking – role up residual risk into quality risk register for organisation Risk Assessment Deviations CAPA SOP Detailed data lifecycle and business processing mapping Identify High Medium Low risk Identify controls commensurate with risk
  • 31. 31© 2015 McGee Pharma International your partner in compliance Data Integrity Governance Plan- Phase 3 & 4 • Check – Phase 3 o Governance team provide tracking and oversight during ‘do’ phase – tracking against project roll out o Important to understand that in the initial phase metrics may appear to look worse as issues are detected through the gap assessment and QRM activities  Communication of this potential ‘Bow Wave’ effect is important o Quick wins actions o Long term actions • Act – Phase 4 – Sustain o Incorporate DI metrics into the Quality Management Review process and track o Incorporate DI into the self inspection & vendor qualification and oversight programs
  • 32. 32© 2015 McGee Pharma International Summary
  • 33. 33© 2015 McGee Pharma International your partner in compliance Summary Overview of Data Integrity •Applies to all data sources •Patient Safety and Product Quality Assurance of Data •Paper based, electronic or hybrid – the same rules apply (ALCOA) •Assuring appropriate data life cycle management •Identifying and controlling internal and external factors Data Governance •The core of data governance is creating a framework to ensure that data generated is recorded, processed, retained & used to ensure complete, consistent & accurate throughout the life cycle •Cultural barriers and lack of senior-level sponsorship may be potential obstacles •Reverting from automated / computerised to manual / paper-based systems will not in itself remove the need for data integrity controls The Data Governance Plan •Should consider prevention and detection •Relevant policies, standards, staff training, consideration should be given to the organisational controls , technical controls •Effort and resource applied should be commensurate with criticality in terms of impact to product quality attributes • Governance at a Management Level and roll out at a grass roots •Things may appear worse before they get better – metrics •PQS, QRM and QMR
  • 34. 34© 2015 McGee Pharma International your partner in compliance Questions?
  • 35. 35© 2015 McGee Pharma International Contact A | Suite 2, Stafford House, Strand Road, Portmarnock, Co. Dublin, Ireland P | +353 (0)1 846 47 42 E | info@mcgeepharma.com F | +353 (0)1 846 4898 W| www.mcgeepharma.com